未登录

D

Danielle Kamato

University of Queensland

H指数:29

被引数:3,830

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Advances in, and prospects of, 3D preclinical models for skin drug discovery

皮肤药物发现的3D临床前模型的进展和前景

DRUG DISCOVERY TODAY

IF7.5

2024-12-010

OAAI

Smad transcription factors as mediators of 7 transmembrane G protein-coupled receptor signalling

ACTA PHARMACOLOGICA SINICA

IF8.4

2024-11-060

OAAI

Response to retention hypothesis as a source of targets for arterial wall-directed therapies to prevent atherosclerosis: A critical review

ATHEROSCLEROSIS

IF5.7

2024-10-011

OAAI

Mechanistic insight: Linking cardiovascular complications of inflammatory bowel disease

TRENDS IN CARDIOVASCULAR MEDICINE

IF9

2024-04-015

OAAI

Transforming growth factor-β receptors: versatile mechanisms of ligand activation

ACTA PHARMACOLOGICA SINICA

IF8.4

2024-02-1312

OAAI

Mouse models of atherosclerosis in translational research

TRENDS IN PHARMACOLOGICAL SCIENCES

IF19.9

2022-11-0141

OAAI

Influence of PEGylated porous silicon nanoparticles on permeation and efflux of an orally administered antibiotic

MATERIALS TODAY ADVANCES

IF8

2022-03-019

OAAI

Lipopolysaccharide acting via toll-like receptor 4 transactivates the TGF-β receptor in vascular smooth muscle cells

脂多糖通过toll样受体4激活血管平滑肌细胞中的tgf-β 受体

CELLULAR AND MOLECULAR LIFE SCIENCES

IF6.2

2022-02-057

OAAI

Endothelin-1 mediated glycosaminoglycan synthesizing gene expression involves NOX-dependent transactivation of the transforming growth factor-β receptor

MOLECULAR AND CELLULAR BIOCHEMISTRY

IF3.7

2022-01-0412

PRE

Akt acts as a switch for GPCR transactivation of the TGF-β receptor type 1

IF4.2

2021-12-188

PRE

11, a camel milk-derived peptide, inhibits TGF-β-mediated atherogenic signaling in human vascular smooth muscle cells

JOURNAL OF FOOD BIOCHEMISTRY

IF4.2

2021-07-271

OAAI

Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies

PHARMACOLOGICAL REVIEWS

IF17.3

2021-07-01532

OA

Endothelial Dysfunction and Cardiovascular Disease: History and Analysis of the Clinical Utility of the Relationship

IF3.9

2021-06-2048

OAAI

Curcumin Inhibits Lysophosphatidic Acid Mediated MCP-1 Expression via Blocking ROCK Signalling

IF4.6

2021-04-1619

OAAI

Targeted Molecular Imaging of Cardiovascular Diseases by Iron Oxide Nanoparticles

氧化铁纳米颗粒对心血管疾病的靶向分子成像

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

IF7.4

2021-02-0154

OAAI

Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: from pharmacology to pre-clinical and clinical therapeutics

钠-葡萄糖协同转运蛋白2 (SGLT2) 抑制剂对动脉粥样硬化的影响: 从药理学到临床前和临床治疗

IF13.3

2021-01-0187

OAAI

Smad2 linker region phosphorylation is an autonomous cell signalling pathway: Implications for multiple disease pathologies

Smad2接头区域磷酸化是一种自主的细胞信号通路: 对多种疾病病理的影响

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2020-04-0121

OAAI

Lysophosphatidic acid and its receptors: pharmacology and therapeutic potential in atherosclerosis and vascular disease

PHARMACOLOGY & THERAPEUTICS

IF12.5

2019-12-0143

PREAI

Smad linker region phosphorylation is a signalling pathway in its own right and not only a modulator of canonical TGF-β signalling

CELLULAR AND MOLECULAR LIFE SCIENCES

IF6.2

2019-08-1240

OAAI

Mechanisms of PAR-1 mediated kinase receptor transactivation: Smad linker region phosphorylation

cell communication and signaling

IF3.9

2019-07-0921

OAAI